SOCIAL MEDIA PUBLIC COMMENTS AND MENTIONS POLICY – SEPUL BIO
SOCIAL MEDIA PUBLIC COMMENTS AND MENTIONS POLICY – SEPUL BIO
Purpose of the document
The social media public comments and mentions policy document is applicable to all social network accounts published by Sepul Bio (LinkedIn page). The purpose of these corporate accounts is to provide the audiences with contextual information on inherited retinal diseases with a focus on Sepofarsen and Ultevursen (information about pathologies, ophthalmic congresses, etc.) and news about Sepul Bio at corporate level.
Acceptance
By joining and using Sepul Bio’s social media account, you agree that you have read and will follow the following rules that are stated on the social media public comments and mentions policy. Please take a moment to acquaint yourself with these important rules. Your use of, participation in, or engagement with our social media channels constitutes your acknowledgement and acceptance of this Policy.
Rules
While we give support to followers to share thoughts and opinions on Sepul Bio’s social media page, we expect that this will be done in a respectful way. First, please understand that we work in a regulated industry and cannot engage in sensitive topics, such as discussions about products (ours or other pharmaceuticals companies’) or treatment options on the pages. These discussions are best held privately with your healthcare professional.
By browsing or sharing content on Sepul Bio’s social network accounts, followers acknowledge that they have accepted the social media public comments and mentions policy and undertake to follow all the rules stated in this document. The policy is available on the social media page of Théa.
Be aware that the Sepul Bio social media public comments and mentions policy apply only to Sepul Bio social network accounts, and not to websites/social networks owned by third parties.
Sepul Bio Corporate accounts offer users the possibility to comment and make contributions. Be aware that Sepul Bio does not agree with or favor every comment that individuals post on our pages. Our target is to share ideas and information with as many individuals as possible and our policy is to accept most of the comments made to our profiles.
Therefore, a comment will be deleted if it contains:
Products with promotional mentions
Health offers or medical advice
Profanity, obscenity or vulgarity,
Nudity in profile pictures,
Defamation to a person or people,
Name calling and/or personal attacks,
Comments which main purpose are to sell a product, service, to recruit fans and followers
Comments that infract on copyrights,
Spam comments, such as the same comment posted repeatedly on a profile,
Any comment that is manifestly unlawful under the applicable laws and regulations and/or constitutes a criminal offence.
All links posted as comments on Sepul Bio posts will be reviewed and may be deleted. Repeated violations of the Sepul Bio comment policy may cause the writer to be blocked from the Sepul Bio’s social media profiles in the context of a posteriori moderation.
This a posteriori moderation is carried out within 24 hours from the publication of the comments in accordance with the applicable regulations and Sepul Bio’s procedures, in particular the regulations relating to pharmacovigilance/quality, pharmaceutical regulations, regulations relating to the protection of personal data and the Law of 21 June 2004 for Confidence in the Digital Economy (LCEN). This moderation is applicable to Sepul Bio’s social network accounts allowing comments/contributions and aims to ensure that these comments comply with the Sepul Bio comment policy and, more generally, with the applicable regulations. In particular, it aims to ensure that no quotation and/or direct or indirect reference to a medicine is made in the comments, as information relating to medicinal treatments may be assimilated to advertising within the meaning of article L.5122-6 of the Public Health Code.
Data Protection
We are not collecting any data from your LinkedIn profile (like email, ID or other personal details) except in the following cases:
In case of clinical trial or heath event you report to us, the personal information collected in connection with your adverse event report is processed by Sepul Bio and its parent company Laboratoires Théa S.A.S., the controller, for the purpose of preventing, monitoring, evaluating and managing adverse health events related to our products.
The personal data we collect is limited to that which is strictly necessary for the assessment of the adverse health event:
Concerning the person exposed to the adverse event: date of birth, sex, weight, height, health data, other data necessary to assess the adverse event (e.g. risk factors such as smoking, alcohol or use of drugs);
Concerning the reporter: surname, first name, postal address, telephone numbers, email address, details of whether the reporter is a health professional and his/her speciality, whether the reporter is related to the patient, whether the reporter is a member of an approved association, whether the reporter is a member of a health authority, etc.
The reporter’s contact details are necessary to be able to contact him/her in order to obtain a satisfactory level of quality and complete information on the reported adverse health event.
The collection and processing of these data are necessary to comply with our pharmaceutical regulation. The recipient of the data are the pharmacovigilance/regulatory services.
Your personal data will be kept for the applicable legal period and will only be accessible to authorized personnel.
You have the right to request access, rectification and, in some cases, deletion of your data. For any request or to obtain more information about the processing of your personal data, please contact us by email at privacy.corporate@theapharma.com or by mail at Laboratoires Théa, DPO, 12 rue Louis Blériot, ZI du Brézet, 63100 Clermont-Ferrand.
If you want to contact us in order to declare or obtain more information about any inquiries, medical side effect during clinical trial phases please used the contact form Contact Sepul Bio : usher syndrome 2B or LCA 10 – Théa. We will also collect some personal data (name, location, health information etc.). The collection and processing of these data are necessary to comply with our pharmaceutical regulation. The recipient of the data are the pharmacovigilance/quality/regulatory services.
We understand that social media is a 24/7 medium; despite, our moderation faculties are not. We may not see every improper comment right away, and we are trusting in the wisdom of our community to avoid personal attacks and negative speech or behave politely.
